StockTipsArenaBeta

BUY Orchid Pharma Limited — Madhu Bansal

BUYOrchid Pharma Limited
Orchid Pharma share price target & all analyst calls

byMadhu BansalHorizon: NA (inferred Swing (≤2wk))8 Jul 2026via CNBC Awaaz.

Entry₹997.9Inferred
Target₹1,200
Total upside +20.25% (call closed)
Stop lossNot given
At expiry₹1,022.721 Jul 2026, 3:30 pm
Expired+2.49%
Follow Madhu Bansal for new calls(24% target hit, 50 closed calls)Get alertsWatch ORCHPHARMA for new buy/sell callsGet alertsSee 147 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 21 Jul 2026
2 supporting3 neutral0 opposing
Supports the BUY call (2)

Orchid Pharma Ltd entered into a licensing and supply agreement with Pharmasyntez JSC, Russia.

BSE · Company Update·7 Jul · 2w ago

(opens in new tab)

Orchid Pharma has entered into a licensing and supply agreement with Russia's Pharmasyntez JSC to commercialize its antibiotic Exblifep in Russia. This partnership is expected to generate approximatel

NSE · Press Release·7 Jul · 2w ago

(opens in new tab)
Neutral / worth noting (3)

Orchid Pharma Limited has set July 23, 2026, as the record date for its merger/hive-off.

NSE · Record Date·10 Jul · 1w ago

(opens in new tab)

The Board Meeting of Orchid Pharma Limited noted the effect of the Scheme of Amalgamation.

NSE · Outcome of Board Meeting·10 Jul · 1w ago

(opens in new tab)

Orchid Pharma Limited has provided an update regarding the Scheme of Amalgamation with Dhanuka Laboratories Limited.

BSE · Company Update·10 Jul · 1w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Orchid Pharma

All analyst calls on Orchid Pharma

More from Madhu Bansal

Every call and its outcome